معرفی
Katie Martin is an Assistant Professor in the Department of Pediatrics and Human Development at Michigan State University (MSU). Her research focuses on mTOR pathway biology, autophagy in cancer cell survival, and the genomic landscape of Tuberous Sclerosis Complex (TSC). Prior to joining MSU, she held roles including Scientific Project Leader at the Van Andel Research Institute and earned her Ph.D. in Cell and Molecular Biology from MSU.
Dr. Martin’s work integrates technologies to study autophagic flux in tumors, aiming to develop autophagy-inhibition therapies. Her TSC research has created a molecular catalog aiding understanding of lesion origins and tumor syndromes. She also explores clinical trial designs, environmental sustainability in healthcare training, and dietary interventions in neurological disorders.
Key research themes include autophagy regulation, kinase inhibitor development, and translational oncology. Her articles span computational biology, clinical protocols, and genetic analyses. She collaborates on interdisciplinary projects involving AI-driven drug screening and patient engagement.
Dr. Martin has contributed to guidelines for autophagy assay standards and pioneered studies on mitochondrial dynamics. Her work bridges basic science and clinical applications, emphasizing translational outcomes in pediatric and adult cancers.
